How Does Forteo Work? Mechanism of Action Explained in Plain English

Most osteoporosis medications work by putting the brakes on bone breakdown. Forteo (teriparatide) does something fundamentally different: it actively tells your body to build new bone. To understand why this matters, it helps to understand how bone works—and what makes Forteo's mechanism uniquely powerful.

A Quick Primer: How Bone Remodeling Works

Bone isn't static—it's constantly being broken down and rebuilt in a process called remodeling. Two main cell types control this:

Osteoclasts: Cells that break down (resorb) old or damaged bone

Osteoblasts: Cells that build new bone

In healthy young adults, these two forces are balanced. In osteoporosis, bone breakdown outpaces bone formation—leading to weakened, porous bones prone to fracture. Most osteoporosis drugs (bisphosphonates, denosumab) work by suppressing osteoclast activity to slow breakdown. Forteo takes the opposite approach: it turbocharges osteoblast activity to accelerate formation.

What Is Teriparatide?

Teriparatide is a synthetic (lab-made) version of the first 34 amino acids of human parathyroid hormone (PTH). Your parathyroid glands produce PTH naturally to regulate calcium and phosphate in your blood and bones. Teriparatide is identical in structure to that 34-amino-acid N-terminal fragment—the part of PTH that activates the parathyroid hormone 1 receptor (PTH1R) on bone cells.

The Key Insight: Continuous vs. Intermittent PTH Exposure

Here's the elegant science behind why Forteo works the way it does:

Continuous high PTH (like in hyperparathyroidism disease) = bone resorption dominates. Too much PTH, all the time, breaks down bone.

Intermittent, once-daily PTH spikes (like a Forteo injection) = bone formation dominates. Brief daily pulses of PTH stimulate osteoblasts more powerfully than osteoclasts.

After you inject Forteo, teriparatide reaches peak blood concentration in about 30 minutes and is cleared from your system within 3 hours. That brief daily pulse is enough to activate osteoblasts and trigger bone formation—without sustaining osteoclast activity long enough for significant breakdown.

How Teriparatide Activates Bone Formation: Step by Step

You inject Forteo subcutaneously into your thigh or abdomen.

Teriparatide absorbs into the bloodstream and reaches bone cells.

It binds to PTH1R receptors on the surface of osteoblasts and osteocytes (a type of embedded bone cell).

This binding activates a cascade of signals inside the cell that promotes osteoblast survival, proliferation, and bone matrix production.

Over time, osteoblasts lay down new collagen framework (osteoid) that mineralizes into dense bone.

After approximately 3 hours, teriparatide is cleared from the blood. The bone-building signal has been delivered and the cycle resets.

What Results Can Patients Expect?

Clinical studies have shown that teriparatide can increase bone mineral density (BMD) in the spine by approximately 7–8% after one year of treatment—a meaningful gain that translates into significantly reduced fracture risk. In the landmark fracture prevention trial, teriparatide reduced the risk of new vertebral fractures by about 65% compared to placebo.

BMD improvements are typically most dramatic in the lumbar spine, with meaningful but smaller gains at the hip.

How Is Forteo Different from Tymlos and Evenity?

All three are anabolic osteoporosis agents, but they work differently:

Forteo (teriparatide): PTH 1-34 analog; activates PTH1R receptor; daily injection; stimulates both formation and some resorption

Tymlos (abaloparatide): PTHrP 1-34 analog; also activates PTH1R receptor; daily injection; similar mechanism, slightly less resorption stimulation

Evenity (romosozumab): Sclerostin inhibitor (monoclonal antibody); blocks a protein that suppresses osteoblasts; monthly injection; promotes formation AND inhibits resorption simultaneously

Why Does the 2-Year Limit Exist?

In animal studies, high doses of teriparatide over a lifetime caused osteosarcoma in rats. Dose and duration were factors. As a precaution, the FDA limits Forteo use to 2 years over a patient's lifetime. Human observational studies have not confirmed this risk, but the precautionary limit remains.

The Bottom Line

Forteo works by delivering a brief daily pulse of parathyroid hormone that tricks your body's bone-building cells into ramping up new bone production. This mechanism is distinct from all antiresorptive therapies and uniquely effective for severe, high-fracture-risk osteoporosis. For a broader overview of what Forteo is and who it's for, see our guide: What is Forteo?